Muscle Relaxation Clinical Trial
Official title:
Correlation of Train Of Four (TOF) With Frontal EMG Parameter Measured by Patient State Index (PSI) Monitor in Extubation Phase of General Anesthesia
NCT number | NCT03926650 |
Other study ID # | ErzincanUnv |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2019 |
Est. completion date | August 1, 2020 |
Verified date | April 2021 |
Source | Erzincan University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The Train Of Four (TOF) Monitor will be placed on ulnar nerve on right wrist of the patients who has surgery under general anaesthesia. This is for stimulation of adductor pollicis muscle. Sedline (Masimo Electromyography(EMG) and Patient State Index(PSI)) Monitor will be placed on the frontal area of head. After the induction of general anaesthesia the investigators will wait for disappearance of eyelash reflex. TOF monitor will be calibrated and muscle relaxant will be applied. After TOF is %0 and disappearance of thumb movement the patient will be intubated. After surgery the investigators will apply muscle relaxant reversal drugs. Then the investigators will record PSI and EMG parameters when TOF is %0, %25, %50,%75,%90. When TOF is %90 the investigators will extubate the patient. The investigators will record PSI and EMG parameters after 5 minutes.
Status | Completed |
Enrollment | 100 |
Est. completion date | August 1, 2020 |
Est. primary completion date | March 1, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - surgery continues more then 1 hour - between ages 18-65 - ASA I,II and III patients Exclusion Criteria: - The patients who has allergical reactions of the drugs used - neurological or neuromuscular diseases - the patients who use drugs effecting the neuromuscular junction - pregnant patients - electrolyte disregulations - major organ failures, liver failure, kidney failure - obese and cachectic patients |
Country | Name | City | State |
---|---|---|---|
Turkey | Erzincan University | Erzincan | Merkez |
Lead Sponsor | Collaborator |
---|---|
Erzincan University |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Patient State Index | Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs | 0 minutes | |
Primary | Patient State Index | Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs | 1 minutes | |
Primary | Patient State Index | Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs | 2 minutes | |
Primary | Patient State Index | Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs | 3 minutes | |
Primary | Patient State Index | Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs | 4 minutes | |
Primary | Patient State Index | Measures anaesthetic awakeness. It can be between 0-100. The investigators will record this parameter after using the reversal drugs | 5 minutes | |
Primary | Electromyography (Frontal EMG) | Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs | 0 minutes | |
Primary | Electromyography (Frontal EMG) | Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs | 1 minutes | |
Primary | Electromyography (Frontal EMG) | Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs | 2 minutes | |
Primary | Electromyography (Frontal EMG) | Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs | 3 minutes | |
Primary | Electromyography (Frontal EMG) | Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs | 4 minutes | |
Primary | Electromyography (Frontal EMG) | Measures frontal muscles' strength.It can be between % 0 - %100. The investigators will record this parameter after using the reversal drugs | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05529420 -
Interindividual Variability in Duration of Action of Rocuronium in Pediatric Patients
|
||
Completed |
NCT01228162 -
Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis Implantation
|
Phase 4 | |
Recruiting |
NCT03801785 -
Efficacy of Non-Nutritive Sucking (NNS) on Balance and Gait Measured in 12-42 Month-Old Healthy Children Over 36 Months
|
N/A | |
Completed |
NCT02778932 -
Comparison of Intubation and Laryngeal Mask for Pars Plana Vitrectomy
|
||
Recruiting |
NCT01389791 -
MgSO4 Combined With Rocuronium Priming
|
N/A | |
Not yet recruiting |
NCT06394245 -
Progressive Relaxation Exercises for Kidney Donors
|
N/A | |
Completed |
NCT04012762 -
Vibration Training and Muscles Properties
|
N/A | |
Recruiting |
NCT03060707 -
Continuous Infusion Versus Intermittent Bolus Injection of Rocuronium
|
Phase 4 | |
Active, not recruiting |
NCT02669368 -
Magnesium Sulfate Effects on Onset and Duration of Low Dose Rocuronium in Patients Undergoing Laparoscopic Cholecystectomy
|
Phase 2 | |
Completed |
NCT01906528 -
Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium
|
Phase 1 | |
Not yet recruiting |
NCT05736744 -
Effect of Magnesium Sulphate Pretreatment in Pediatric Laparoscopy
|
Phase 2/Phase 3 | |
Completed |
NCT03112564 -
Endotracheal Intubation Without Muscle Relaxants
|
N/A | |
Completed |
NCT05432570 -
Use of Muscle Relaxants in Parotidectomy Operation With Neuromonitoring
|
N/A | |
Completed |
NCT00984633 -
Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)
|
Phase 3 | |
Completed |
NCT03573895 -
Stretching vs Foam-rolling
|
N/A | |
Completed |
NCT03381209 -
The Effect of Sugammadex Given Based on Ideal, Actual or Adjusted Body Weight on Reversal of Rocuronium.
|
N/A | |
Recruiting |
NCT05911867 -
Muscle Energy Technique and Mulligan's Mobilization in Breast Cancer Surgery Patients
|
N/A | |
Recruiting |
NCT05757999 -
Effect of MgSO4 Pretreatment on Muscle Relaxation
|
Phase 2/Phase 3 | |
Completed |
NCT02185339 -
Effects of Deep Neuromuscular Blockade on Intraoperative Respiratory Mechanics
|
Phase 4 | |
Completed |
NCT02498678 -
Effect of Tetanus on Neuromuscular Junction Monitor Performance in Pediatric Patients
|
N/A |